助眠市場：按產品類型、睡眠障礙、地區劃分——規模、份額、展望、機會分析，2022-2030 年

助眠劑可用於治療發作性睡病、睡眠呼吸暫停、發作性睡病、睡眠呼吸暫停、精神障礙（抑鬱和焦慮）、環境問題（光線、噪音、極端溫度）、醫療問題（哮喘）和其他因素。還有稱為催眠藥、安眠藥或用於治療各種睡眠障礙（包括失眠）的裝置。 睡眠障礙的治療包括非苯二氮卓類藥物、抗抑鬱藥和抗精神病藥。 然而，各種行為療法，如光療法、認知行為療法和放鬆技巧，也可用於治療這些疾病。 睡眠障礙是由多種疾病引起的，包括心髒病、肺病、神經系統疾病、精神疾病和抑鬱症。

市場動態

市場主要參與者越來越多地採用有機策略，例如獲得美國 FDA 的許可，預計將在預測期內推動市場增長。 例如，2021 年 2 月，美國 FDA 批准了一種可拆卸舌肌刺激器，這是一種為舌頭提供神經肌肉刺激以減少 18 歲及以上患者打鼾和輕度睡眠呼吸暫停的新型設備，並宣布批准 eXciteOSA。 eXciteOSA 每 6 週每天使用一次，每次 20 分鐘，然後停用 2 週以評估療效。 該設備通過一個稱為電肌肉刺激的過程使用適合您舌頭的咬嘴來工作。

這項研究的主要特點

• 本報告對全球助眠劑市場進行了深入分析，提供了以 2021 年為基準年的預測期（2022-2030 年）內市場規模和復合年增長率 (CAGR%) 的增長情況。
• 解釋了不同細分市場的潛在創收機會，並描述了針對該市場的有吸引力的投資建議矩陣。
• 它還提供重要的見解，例如市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭戰略。
• 根據公司亮點、產品組合、主要亮點、財務業績和戰略等參數介紹全球睡眠輔助設備市場主要參與者的概況。
• 本研究涵蓋的主要公司包括賽諾菲、默克公司、輝瑞公司、Koninklijke Philips N.V.、GSK plc、Sommetrics, Inc.、ResMed、Cadwell Industries, Inc.、SleepMed, Inc.、 Sci Sparc、Natus Medical Incorporated、Therapix Biosciences Ltd、Compumedics Limited、AstraZeneca、Eisai Co., Ltd.、Tris Pharma, Inc.、Novartis AG、Fisher & Paykel Healthcare Limited、Rotech Healthcare Inc.、Idorsia Pharmaceuticals Ltd.、StimScience
• 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。看來。
• 本報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球睡眠輔助市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第二章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 按產品類型劃分的市場概況
  • 市場概況：按睡眠障礙分類
  • 市場概況：按地區
• 連貫機會圖 (COM)

第 3 章市場動態、法規和趨勢分析

• 市場動態
  • 司機
  • 約束因素
  • 市場機會
• 影響分析
• 市場趨勢
• 近期趨勢
• 收購和合作場景
• 技術概述
• 監管場景
• 管道分析
• 害蟲分析

第 4 章全球安眠藥市場：冠狀病毒 (COVID-19) 疫情的影響

• 總體影響
• 對供需的影響
• COVID-19 對市場的影響

第 5 章全球睡眠輔助市場：按產品類型，2017-2030

• 藥物
• 床墊和枕頭
• 睡眠呼吸暫停綜合徵設備
• 其他

第 6 章全球助眠劑市場：按睡眠障礙分類，2017-2030

• 失眠
• 睡眠呼吸暫停綜合症
• 不寧腿綜合症
• 發作性睡病
• 恐夜症
• 其他

第 7 章按地區分列的全球安眠藥市場，2017-2030

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地區
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲地區
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 其他亞太地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中非
• 南非

第八章競爭格局

• Sanofi
• Merck & Co., Inc.
• Pfizer Inc.
• Koninklijke Philips N.V.
• GSK plc.
• Sommetrics, Inc.
• ResMed
• Cadwell Industries Inc.
• SleepMed, Inc.
• Sci Sparc
• Natus Medical Incorporated.
• Therapix Biosciences Ltd
• Compumedics Limited
• AstraZeneca
• Eisai Co., Ltd.
• Tris Pharma, Inc.
• Novartis AG
• Fisher & Paykel Healthcare Limited
• Rotech Healthcare Inc.
• Idorsia Pharmaceuticals Ltd
• StimScience

第 9 章

• 調查方法
• 關於出版商

Sleeping aids, are also known as hypnotics, sleeping pills or devices used in the treatment of various sleeping disorders such as narcolepsy, sleep apnea, and insomnia, which are caused due to factors such as psychiatric disorders (Depression and anxiety), environmental problems (light, noise and extreme temperatures) medical issues (asthma) and others. Sleeping aid medications include non-benzodiazepines, antidepressants, and antipsychotics for the treatment of sleeping disorders. However, various behavioral therapies such as light therapy, cognitive behavioral therapy, and relaxation techniques are also used in the treatment of these disorders. Sleep disorders are caused by different diseases such as heart disease, lung disease, nerve disorders, mental illness, and depression.

Market Dynamics

Increasing adoption of organic strategies by key players in market such as obtaining authorization by the U.S FDA is expected to drive market growth over the forecast period. For instance, in February 2021, the U.S. FDA announced the authorization of a novel device eXciteOSA, a removable tongue muscle stimulation device which delivers neuromuscular stimulation to the tongue to reduce snoring and mild sleep apnea for patients 18 years or older. The U.S. FDA has assessed the safety as well as effectiveness of the eXciteOSA and studied in 115 patients with snoring and mild apnea. eXciteOSA device is used for 20 minutes and once a day for every 6 weeks then discontinued for 2 weeks to study and assess the device. eXciteOSA device is reviewed through De-Novo premarket review pathway, for low to moderate risk device. It works by process called electric muscle stimulation through mouthpiece that sits around the tongue.

Key features of the study:

• This report provides an in-depth analysis of the global Sleep Aids Market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Sleep Aids Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Sanofi, Merck & Co., Inc, Pfizer Inc., Koninklijke Philips N.V., GSK plc, Sommetrics, Inc., ResMed, Cadwell Industries, Inc., SleepMed, Inc., Sci Sparc, Natus Medical Incorporated, Therapix Biosciences Ltd, Compumedics Limited, AstraZeneca, Eisai Co., Ltd., Tris Pharma, Inc., Novartis AG, Fisher & Paykel Healthcare Limited, Rotech Healthcare Inc., Idorsia Pharmaceuticals Ltd., StimScience
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global Sleep Aids Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Sleep Aids Market

Detailed Segmentation:

• Global Sleep Aids Market, By Product Type:
  • Medication
  • Mattresses and pillows
  • Sleep apnea devices
  • Others
• Global Sleep Aids Market, By Sleep Disorder:
  • Insomnia
  • Sleep apnea
  • Restless legs syndrome
  • Narcolepsy
  • Night terrors
  • Others
• Global Sleep Aids Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Sanofi
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck & Co., Inc,
  • Pfizer Inc.,
  • Koninklijke Philips N.V.,
  • GSK plc,
  • Sommetrics, Inc.,
  • ResMed,
  • Cadwell Industries, Inc.
  • SleepMed, Inc.
  • Sci Sparc
  • Natus Medical Incorporated
  • Therapix Biosciences Ltd
  • Compumedics Limited.
  • AstraZeneca
  • Eisai Co., Ltd
  • Tris Pharma
  • Novartis AG
  • Fisher & Paykel Healthcare Limited
  • Rotech Healthcare Inc.
  • Idorsia Pharmaceuticals Ltd
  • StimScience

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Sleep Disorder
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• Pipeline Analysis
• PEST Analysis

4. Global Sleep Aids Market- Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the market

5. Global Sleep Aids Market, By Product Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Medication
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Mattresses and Pillows
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Sleep Apnea Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Sleep Aids Market, By Sleep Disorder, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Insomnia
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Sleep Apnea
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Restless Legs Syndrome
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Narcolepsy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Night Terrors
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Sleep Aids Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

8. Competitive Landscape

• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Merck & Co., Inc.
• Pfizer Inc.
• Koninklijke Philips N.V.
• GSK plc.
• Sommetrics, Inc.
• ResMed
• Cadwell Industries Inc.
• SleepMed, Inc.
• Sci Sparc
• Natus Medical Incorporated.
• Therapix Biosciences Ltd
• Compumedics Limited
• AstraZeneca
• Eisai Co., Ltd.
• Tris Pharma, Inc.
• Novartis AG
• Fisher & Paykel Healthcare Limited
• Rotech Healthcare Inc.
• Idorsia Pharmaceuticals Ltd
• StimScience

9. Section

• Research Methodology
• About Us